Logo
Logo
LOGIN
SUBSCRIBE
EXPERIENCE PSILOCYBIN
SHOP MERCH
WORK WITH US
ARCHIVE
Logo
Logo

BACK ISSUES

This Week in Psychedelics

Our flagship Wednesday newsletter breaks down the latest and greatest updates across psychedelic research, policy, and business. It’s serious psychedelic news, delivered with personality… and memes. Gotta have the memes.

READ MORE

Ask a Guide Anything

Every Friday, we source one burning question directly from you, dear readers, and pitch it to our network of vetted psychedelic practitioners. There are no stupid questions, but we do love a good brain buster.

READ MORE

Psychonaut POV

On Sundays, we spotlight a luminary in the psychedelic field with a feature interview. It could be a clinician, a researcher, an entrepreneur, an advocate… variety is the spice of life. These pioneers don’t all always agree, and that’s part of what makes the series great.

READ MORE

ARCHIVE

🫠 Psychonaut POV

Jun 2, 2024

🫠 Psychonaut POV

[5-min read] Q&A with Mary Olivar, Director of Development

Henry Winslow
Henry Winslow
🫠 This Week in Psychedelics

May 29, 2024

🫠 This Week in Psychedelics

[5-min read] NY bill would legalize psilocybin use with a permit.

Henry Winslow
Henry Winslow
🫠 Psychonaut POV

May 26, 2024

🫠 Psychonaut POV

[5-min read] Q&A with Christopher Solomon, Somatic Salvia Guide

Henry Winslow
Henry Winslow
🫠 This Week in Psychedelics

May 22, 2024

🫠 This Week in Psychedelics

[5-min read] California psychedelic therapy bill gets killed in committee.

Henry Winslow
Henry Winslow
🫠 Psychonaut POV

May 19, 2024

🫠 Psychonaut POV

[5-min read] Q&A with Bia Labate, Anthropologist & Director

Henry Winslow
Henry Winslow
🫠 This Week in Psychedelics

May 15, 2024

🫠 This Week in Psychedelics

[5-min read] AbbVie inks a $2B deal with psychedelic biotech Gilgamesh Pharma.

Henry Winslow
Henry Winslow
🫠 Psychonaut POV

May 12, 2024

🫠 Psychonaut POV

[5-min read] Q&A with Zach Leary, Facilitator & Educator

Henry Winslow
Henry Winslow
🫠 This Week in Psychedelics

May 8, 2024

🫠 This Week in Psychedelics

[5-min read] Oxford study identifies patient types who benefit from psilocybin therapy.

Henry Winslow
Henry Winslow
🫠 Psychonaut POV

May 5, 2024

🫠 Psychonaut POV

[5-min read] Q&A with Joël Brierre, Founder & CEO

Henry Winslow
Henry Winslow
🫠 This Week in Psychedelics

May 1, 2024

🫠 This Week in Psychedelics

[4-min read] Congress sets a deadline for the VA's MDMA implementation plan.

Henry Winslow
Henry Winslow
🫠 Psychonaut POV

Apr 28, 2024

🫠 Psychonaut POV

[5-min read] Q&A with Reggie Harris, Founder & Educator

Henry Winslow
Henry Winslow
🫠 This Week in Psychedelics

Apr 24, 2024

🫠 This Week in Psychedelics

[5-min read] Church secures its legal right to serve ayahuasca.

Henry Winslow
Henry Winslow
🫠 This Week in Psychedelics

Apr 17, 2024

🫠 This Week in Psychedelics

[5-min read] Psychedelic practitioners face challenges with informed consent.

Henry Winslow
Henry Winslow
🫠 Psychonaut POV

Apr 14, 2024

🫠 Psychonaut POV

[5-min read] Q&A with Tricia Eastman, Medicine Woman & Author

Henry Winslow
Henry Winslow
🫠 This Week in Psychedelics

Apr 10, 2024

🫠 This Week in Psychedelics

[4-min read] New study suggests older adults respond in unique ways to psychedelics.

Henry Winslow
Henry Winslow
LOAD MORE

Stay ahead of the psychedelic movement. Industry news and practical wisdom, with a side of spicy memes. 🫠

I consent to receive newsletters via email. Terms of use and Privacy policy.

EXPERIENCE PSILOCYBIN

SHOP MERCH

work with us

archive

Β© 2026 Tricycle Day.
beehiivPowered by beehiiv